Abstract:
The aim of present research work is to formulate wafer containing antimicrobial agent for
wound infection. Wound is an infectious diseases which can be the result of colonization
of the body by various microorganisms. The main microorganisms on skin are grampositive
cocci (probably staphylococci e.g. Methicillin resistant staphylococcus aureus).
The formulation has sustained release of vancomycin hydrochloride with antibacterial
effect at wound site.The wafer containing antimicrobial agent was prepared by
lyophilization method. FTIR was performed to study drug-excipient compatibility.
Analytical method was developed by UV-spectroscopy. Optimization of formulation was
done by 32 full factorial design. Wafer containing antimicrobial agent was evaluated for
viscosity, % drug content, swelling capacity, water uptake study, In-vitro % cumulative
drug release study, scanning electron microscopy (SEM), In-vivo wound healing study.
Drug content and swelling capacity of optimized batch A3 were 98.06±0.053 % and
852.23± 0.036 % respectively. The % cumulative drug release of optimized batch A3 was
93.78±0.28% up to 16 hrs. Stability study data of optimized batch A3 showed, wafer was
stable at accelerated condition (40°C± 2°C and 75± 5 % RH) after 2 months.From the result it was concluded that the wafer containing antimicrobial agent had maximum drug
release in 16 hrs with good wound healing effect as well as good stability. This research
work proves that the optimized wafer formulation containing vancomycin hydrochloride
is potential drug delivery device against wound infection.
